Skip to product information
1 of 1

IL-12/IL-23 p40 Monomer Protein, Human

IL-12/IL-23 p40 Monomer Protein, Human

Catalog Number: UA040354 Reactivity: Human Conjugation: Unconjugated Brand: UA BIOSCIENCE
Price:
Regular price $164.00 USD
Regular price Sale price $164.00 USD
Size:
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Species Human
Synonyms Interleukin-12 subunit beta; IL-12B; Cytotoxic lymphocyte maturation factor 40 kDa subunit (CLMF p40); IL-12 subunit p40; NK cell stimulatory factor chain 2 (NKSF2);
Accession P29460
Amino Acid Sequence

Ile23-Ser328

Expression System CHO
Molecular Weight

40 kDa (Reducing)

Purity >95% by SDS-PAGE and HPLC.
Endotoxin <0.1EU/μg
Conjugation Unconjugated
Tag No Tag
Physical Appearance Lyophilized Powder
Storage Buffer PBS, pH7.4
Reconstitution

Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.

Stability & Storage · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
· 3 months, -20 to -80℃ under sterile conditions after reconstitution.
· 1 week, 2 to 8℃ under sterile conditions after reconstitution.
· Please avoid repeated freeze-thaw cycles.
Reference

Nat Med. 2015 Jul;21(7):719-29. Epub 2015 Jun 29.

Background

The IL-12/IL-23 p40 monomer is a subunit shared between the interleukin-12 (IL-12) and interleukin-23 (IL-23) cytokines. It is a critical component of both the IL-12 and IL-23 heterodimers, which are proinflammatory cytokines that play essential roles in regulating immune responses. The IL-12/IL-23 p40 monomer is involved in the formation of the biologically active IL-12 and IL-23 heterodimers, which bind to their respective receptors and activate signaling pathways that modulate immune cell function. Notably, the p40 subunit itself has been shown to exhibit biological activity independent of its role in forming the heterodimers, including the ability to act as an antagonist for IL-12 and IL-23 signaling by competing for receptor binding.

Picture

Bioactivity

Measured by its ability to enhance IFN-gamma secretion in NK-92 human natural killer lymphoma cells. The EC50 for this effect is less than 10ng/ml.

SDS-PAGE

2μg (R: reducing condition, N: non-reducing condition).

SEC-HPLC

>95% as determined by SEC-HPLC.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)